A clinical study showed that CD56dimCD16− and CD56brightCD16− NK cells represent the predominant NK cell subpopulations in acute myeloid leukemia (AML) and that CD39+/CD38+ cells cluster on CD56brightCD16− NK cells. Here, ENTPD1 is linked to acute myeloid leukemia.